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Synopsis
The common severe Z mutation (E342K) of α1-antitrypsin forms intracellular polymers that are associated with liver
cirrhosis. The native fold of this protein is well-established and models have been proposed from crystallographic
and biophysical data for the stable inter-molecular configuration that terminates the polymerization pathway. Despite
these molecular ‘snapshots’, the details of the transition between monomer and polymer remain only partially
understood. We surveyed the RCL (reactive centre loop) of α1-antitrypsin to identify sites important for progression,
through intermediate states, to polymer. Mutations at P14P12 and P4, but not P10P8 or P2P1′ , resulted in a decrease
in detectable polymer in a cell model that recapitulates the intracellular polymerization of the Z variant, consistent
with polymerization from a near-native conformation. We have developed a FRET (Fo¨rster resonance energy transfer)-
based assay to monitor polymerization in small sample volumes. An in vitro assessment revealed the position-specific
effects on the unimolecular and multimolecular phases of polymerization: the P14P12 region self-inserts early during
activation, while the interaction between P6P4 and β -sheet A presents a kinetic barrier late in the polymerization
pathway. Correspondingly, mutations at P6P4, but not P14P12, yield an increase in the overall apparent activation
energy of association from ∼360 to 550 kJ mol−1.
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INTRODUCTION
The serine protease inhibitor (serpin) superfamily plays import-
ant roles in controlling a wide range of proteolytic cascades [1]. A
serpin in its inhibitory form can be viewed as a metastable folding
intermediate that converts to an extremely stable state on proteo-
lytic cleavage of an exposed ‘RCL’ (reactive centre loop), as
summarized in Figure 1(A). This transition forms the basis of the
serpin inhibitory mechanism [2]. Point mutations that perturb
the balance between metastable and stable states result in dis-
eases, termed serpinopathies, in which ordered polymers are re-
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tained within the endoplasmic reticulum of the cell of synthesis
[3], and aggregate as inclusions associated with toxicity and cell
death [4]. The archetypal serpinopathy is α1-antitrypsin defi-
ciency, in which the affected individuals can develop neonatal
hepatitis and cirrhosis and early onset emphysema [5].
Polymers can be induced in vitro at elevated temperatures
[6,7], by proteolytic digestion following the P6, P7 or P10 residues
[8–10], by low concentrations of denaturant [6,7], by a pep-
tide mimetic of the P14–P9 residues of the RCL [11,12] or at
low pH [13]. A mechanism has been proposed, which describes
the transition from monomer (M) to polymer (P) in which the
monomer is ‘activated’ to an intermediate state (Ipol), which then
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Figure 1 RCL mutants of α1-antitrypsin
(A) The location of the mutations used in this study are indicated against a cartoon representation of wild-type α1-antitrypsin
(prepared using PyMol and PDB entries 1QLP [42] and 1EZX [43]). The RCL is highlighted in black, and numbered according
to the P-site convention of Schechter and Berger [28], in which the P1 and P1′ positions are either side of the site of cleavage
by a cognate protease. The three β -sheets of the serpin fold and the F-helix are labelled. Upon transition from the native,
active conformation (left panel) to the cleaved or latent forms, the RCL moves from an exposed to an inserted position as
an additional β -strand of β -sheet A (right panel). (B) The three main models of polymerization: i, a molecular model of a
loop-sheet polymer; ii, the crystal structure of a closed dimer of antithrombin; iii, a closed trimer of α1-antitrypsin. The site
of inter-molecular interaction in each form is shown in black and helix F is coloured cyan. (C) Mutations at positions P14P12,
P6P4 and P4 of the RCL reduce intracellular polymerization of Z α1-antitrypsin. COS-7 cells were transiently transfected with
M α1-antitrypsin, Z α1-antitrypsin and RCL mutants on a Z α1-antitrypsin background in serum-free medium for 24 h before
lysis. A sandwich ELISA analysis of intracellular polymers made use of the polymer-specific 2C1 monoclonal antibody. The
results are normalized to Z α1-antitrypsin (n=4; mean+−S.D.) and differences were assessed by one-way ANOVA with
Bonferroni’s correction for multiple comparisons: *, P<0.01; **, P<0.001. The value for M α1-antitrypsin is shown
with a dotted line (M).
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RCL in intermediate formation
self-associates (P) or is converted into a monomeric inactive form
(L) [14–16]:
M ↔ Ipol
↓
L
+Ipol
−−→ P
During the activation to intermediate, there is a change in far-
UV circular dichroic signal, intrinsic tryptophan fluorescence, the
interaction with ANS (8-anilinonaphthalene-1-sulfonic acid) or
bis-ANS (4,4′-dianilino-1,1′-binaphthyl-5,5′-disulfonic acid)
dyes [14,17], ion mobility mass spectrum collision cross-
sectional area [18] and NMR cross-peaks [19]. While denaturant
can induce polymerization at concentrations that favour popula-
tion of an unfolding intermediate state (Idenat) [6,20], observations
indicate that there are multiple pathways favoured depending
on the manner in which polymers are formed, and as a result
intermediate ensembles represented by Ipol and Idenat could be
structurally distinct [19]. In support of this, it has recently been
shown that polymers produced in the presence of denaturant lack
an epitope that is expressed on polymer obtained from patient
samples [18,21]. Given this diversity it is unsurprising that there
are currently three main models for the terminal polymer that
differ from one another in fundamental respects (Figure 1B).
The RCL-to-β-sheet A linkage ‘loop-sheet’ model, supported
by a considerable amount of biophysical data [2,6,8,10,22], has
recently been joined by two models that are based on crystal
structures of self-terminating oligomers: a circular dimer of an
antithrombin mutant with an RCL-strand 5A β-hairpin domain
swap [23], and a circular trimer of α1-antitrypsin formed in the
presence of an engineered disulfide bond with a triple strand 1C–
5B–6B domain swap [24]. The extent of the regions exchanged
in these latter two structures has led to the proposal that the cor-
responding polymerization intermediates will involve substantial
unfolding of some secondary structure elements.
While the main polymer models disagree in the nature of the
inter-molecular linkage, they all predict an expanded 6-strand
β-sheet A with RCL residues accommodated in the equivalent
positions to that seen in the canonical cleaved conformation. This
is consistent with the observation that α1-antitrypsin polymeriza-
tion can be induced or blocked by incorporation of an exogenous
peptide mimic of the RCL into β-sheet A [6,25,26]. The evidence
therefore substantively implicates the RCL as a critical compon-
ent of the mechanism of polymerization, while the extent of RCL
insertion during intermediate (Ipol) formation varies between the
most parsimonious interpretations of the different models: partial
or none in the case of the loop-sheet and the β-hairpin forms, and
full insertion in the triple-strand model.
In order to assess the relative contribution of different RCL po-
sitions to Ipol, we replaced the residues that are accommodated by
β-sheet A in the cleaved and latent forms (P14, P12, P10 , . . . , P1′ )
with aspartic acid [12] (Figure 1A). We determined the effect of
these mutations on the rate of activation to the intermediate state
by monitoring changes in tryptophan fluorescence, CD and bind-
ing to bis-ANS, and we report a novel FRET (Fo¨rster resonance
energy transfer)-based polymerization assay.
Reconciliation of the results with features that are common
to the three extant models of the polymer form reveals details
of the pathway. An early structural transition, detectable by
change in CD, precedes partial insertion of the P14P12 residues
into β-sheet A. The interaction of the P6P4 residues with β-sheet
A – whether in an inter- or intra-molecular fashion – occurs late
in the polymerization pathway and presents an energetic barrier
to polymerization.
The observation that polymerization in mammalian cells can
be blocked by mutation of the P6P4 and P14P12 sites suggests that,
in vivo, polymerization occurs from a state with intact strands 3A
and 5A of β-sheets A, and strands 2B, 3B and 4B of β-sheets
B. It is therefore concluded that most likely polymerization oc-
curs from a near-native form rather than a substantially unfolded
intermediate.
EXPERIMENTAL
Plasmid generation for the expression of
recombinant α1-antitrypsin in vitro and in cell
culture
The pQE-30 and pQE-81L plasmids (Qiagen) containing the
‘wild-type’ (M allele) α1-antitrypsin ORF with the C232S
mutation (introducing N-terminal vector-derived amino acids
MRGSHHHHHHT and MRGSHHHHHHTDPHASSVP, re-
spectively) were used to express recombinant α1-antitrypsin [27].
The C232S substitution obviates the need for reducing agent in
the assay buffer and was used as the control for in vitro experi-
ments (ATC232S). This variant has been found to behave in an equi-
valent fashion to wild-type in the previous studies (for example
[22]). Reactive loop mutants were prepared on the C232S back-
ground using aspartic acid-scanning mutagenesis [12] to generate
T345D, A347D, G349D, M351D, L353D, A355D, P357D and
S359D substitutions (corresponding with RCL positions P14, P12,
P10, P8, P6, P4, P2 and P1′ in subsite notation [28]), yielding in
combination the variants P14P12, P10P8, P6P4, P2P1′ , P6 and P4.
The pcDNA plasmid containing the Z (E342K) α1-antitrypsin
allele was used as the basis for the mutants in cell culture exper-
iments [29].
Cell culture, transfection and lysis
COS-7 cells were purchased from the ATCC (American Type Tis-
sue Culture Collection) and maintained in DMEM (Dulbecco’s
modified Eagle’s medium) (Sigma) supplemented with 10 % (v/v)
FBS (Sigma). Two hours prior to transfection the medium was
changed to Optimem (Gibco). The plasmid DNA containing wild-
type, Z or mutants of α1-antitrypsin was transiently transfected
into the COS-7 cells using lipofectamine LTX (Invitrogen). Cells
were lysed after 24 h using 150 mM NaCl/50 mM Tris/0.1 %
(v/v) NP-40 with 25 mM Complete EDTA-free protease inhib-
itor (Roche Applied Science) and α1-antitrypsin polymers were
detected by sandwich ELISA with the α1-antitrypsin polymer-
specific 2C1 antibody as described previously [30].
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Escherichia coli expression and purification of
recombinant α1-antitrypsin
Plasmids containing wild-type and mutated M α1-antitrypsin on
a C232S background were transformed into SG13009/pREP4
cells and BL21 (DE3) cells (Novagen) for pQE-30 and pQE-
81L-based constructs, respectively. Recombinant proteins were
expressed and purified as described previously [30] before buf-
fer exchange into 20 mM Tris, 100 mM NaCl, pH 7.4 and stor-
age at − 80 ◦C. The resulting proteins were assessed by SDS-
and non-denaturing PAGE, CD spectra, thermal stability and for
their ability to inhibit bovine α-chymotrypsin. The different N-
terminal extensions produced by the pQE-30 and pQE-81L ex-
pression systems generated α1-antitrypsin with the same thermal
stability, secondary structure (as evaluated by CD), inhibitory
kinetics and ability to form polymers as described previously
[14,21,31].
Thermal denaturation assay
The stability of α1-antitrypsin was investigated by thermal denat-
uration in the presence of a 5× concentration of SYPRO Orange
dye solution (Life Technologies) in 50 mM Na2HPO4/NaH2PO4
buffer, pH 7.4, at a final protein concentration of 0.1 mg/ml and
in a 20 μl volume [32]. Protein samples were heated from 25 to
95 ◦C at a rate of 1 ◦C min− 1 in three separate experiments on
an Applied Biosystems 7900HT quantitative real-time PCR in-
strument, and the fluorescence in the 625–630 nm bins recorded.
The midpoint of denaturation (Tm) was reported as the temperat-
ure at which the first derivative of fluorescence intensity against
temperature reached a maximum.
Assessment of inhibitory activity of α1-antitrypsin
Bovine α-chymotrypsin (Sigma) was titrated using 4-nitrophenyl
acetate [33]. The SI (stoichiometry of inhibition) of wild-type
and mutants of α1-antitrypsin was determined by incubation of
the protein for 30 min at room temperature with 0.5 μM bovine
α-chymotrypsin in 20 μl protease assay buffer (20 mM Tris,
100 mM NaCl, 0.1 % (w/v) PEG 8000, 10 mM CaCl2, pH8.0).
180 μl of 200 μM N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide
substrate (Sigma) was added and the rate of absorbance increase
at 405 nm was recorded for 5 min using a ThermoMax plate
reader (Molecular Devices). Linear regression was used to extra-
polate the amount of inhibitor required to completely abrogate
enzyme activity. The association rate constant of inhibitor with
enzyme (kass) was measured by reaction progress curves under
pseudo-first-order conditions for 4 h at 25 ◦C with a final con-
centration of 5–600 nM inhibitor, 200 μM substrate and 0.5 nM
bovine α-chymotrypsin. Data analysis was as described previ-
ously [34].
CD analysis
All far-UV spectra were obtained using a Jasco J-810 spectro-
polarimeter with a 0.2 mm pathlength cell. Samples were dia-
lysed into 10 mM Na2HPO4/NaH2PO4, pH 7.4 and adjusted to
0.5 mg/ml prior to analysis. Scanning was performed between
260 and 180 nm at a rate of 50 nm/min, a 0.1 nm pitch and 1 s
response time, with averaging of four spectra per experiment.
A thermal shift assay to evaluate the effect of the ATTO-NTA
(nitrilotriacetic acid) fluorescent probes (described below) was
undertaken by monitoring the CD of the sample at 222 nm in a
2 mm pathlength cuvette, as the sample was heated from 5 to
95 ◦C at a rate of 1 ◦C min− 1. The unimolecular activation as-
say used 0.1 mg ml− 1 protein in 20 mM Na2HPO4/NaH2PO4,
pH 7.4, heated at 55 ◦C in a 10 mm pathlength cell while monit-
oring the output at 222 nm. Data were normalized as a proportion
of the starting signal before fitting in Prism (GraphPad) to a two-
phase exponential equation of the form
It = 1 − Be−k1,cdt − Ce−k2,cdt (1)
where B and C are pre-exponential factors, k1,cd is the apparent
rate of the early transition under the conditions of the assay and
k2,cd is the calculated rate of the late transition.
Polymerization kinetics monitored by FRET
A microplate assay was developed in which the rate of polymer
formation was determined by monitoring FRET between Ni-NTA
(nickel-nitrilotriacetic acid)-conjugated ATTO-550 and ATTO-
647N fluorescent probes (Sigma). These dyes are recruited from
solution to interact non-covalently with the hexahistidine tag of
the variants, and as such it is not possible to measure labelling
efficiency; coupled with the heterogeneous nature of polymeriza-
tion, no inference was therefore made as to the physical distance
between fluorophores. α1-Antitrypsin was diluted to 0.1 mg/ml
in polymerization buffer (10 mM Na2HPO4/NaH2PO4, 0.1 M so-
dium chloride, 0.1 % (w/v) PEG8K, pH 7.4) containing a pool of
2–8 μM ATTO-550-Ni-NTA and 2–8 μM ATTO-647N-Ni-NTA
probes. The ratio of fluorescence intensity of the donor and ac-
ceptor fluorophores was followed for 8–18 h at 50, 55 and 60 ◦C.
Change in fluorescence was monitored for 20 μl samples us-
ing an Applied Biosystems 7900HT quantitative PCR instrument
(which uses a 488 nm laser to excite the donor) and the ratio
of the emitted fluorescence in the 645–660 to 550–600 nm bins
was monitored. FRET efficiency increased to a plateau value; in
some cases this was followed by a gradual decrease interpreted
as precipitation or secondary change in polymer characterist-
ics. Data were normalized as a proportion of the initial FRET
value; it was determined empirically that an overall increase of
less than 5 % corresponded with a lack of polymerization. As
described in the Results section, it was found that best numer-
ical stability was obtained for the fit, using Prism (Graphpad),
of the integrated second-order rate equation for homogeneous
reactants following truncation of the data below 25 % of the total
signal:
Ft
F0
= A
(
1 − 1
1 + kapp.frt
)
+ 1 (2)
where Ft denotes the ratio of acceptor to donor fluorescence (a
measure of FRET efficiency) at time t, F0 is the starting FRET
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efficiency, A is a scaling factor and kapp,fr is the apparent rate
constant under the conditions of the assay. For recording of full
FRET spectra at room temperature, a SpectraMax M5 plate reader
(Molecular Devices) was used, with excitation at 520 nm and
monitoring emission between 550 and 725 nm with 4–10 nm
intervals.
Polymerization monitored by the change in intrinsic
tryptophan fluorescence
A LS55B spectrofluorimeter (Perkin Elmer) fitted with a Peltier
module was used to measure fluorescence of α1-antitrypsin at
constant temperature in polymerization buffer. Samples were di-
luted 200–800-fold into pre-heated buffer to give an 800 μl final
volume in a 4 mm×10 mm stirred quartz cuvette. Samples were
excited at 290 nm and the emission was measured at 340 nm, with
3 nm widths, and the PMT voltage adjusted as appropriate. The
resulting curves were fitted using a single exponential equation
of the form:
It = A + B(1 − e−kapp,flt ) (3)
in which It is the fluorescence intensity at time t, B is the pre-
exponential factor, A the baseline signal and kapp,fl the apparent
rate of polymerization under the conditions of the assay.
Monitoring the formation of an activated
intermediate using bis-ANS
This experiment was conducted both in a microplate format using
a SpectraMax M5 (Molecular Devices) plate reader and in a cu-
vette format using an LS55B spectrofluorimeter (Perkin Elmer).
In both cases, polymerization buffer containing 10 μM bis-ANS
and 0.1 μM fluorescein was pre-heated, samples diluted at least
20-fold, and measurement was initiated immediately. Final mi-
croplate well volume was 200 μl overlaid with 50 μl VaporLock
and cuvette volume was 800 μl; excitation was at 390 nm and
emission at 480 nm, with 2.5 nm/5 nm slit widths on the LS55B
and fixed 9 nm/15 nm bandwidths on the M5 instrument. The
fluorescein was used as a passive reference to correct for light
path anomalies in the microplate assay and detected by excit-
ing at 480 nm and reading the emission at 520 nm; the bis-ANS
measurement was normalized against this value. Curves were fit
to a single exponential equation.
RESULTS AND DISCUSSION
RCL mutants affect the accumulation of
intracellular Z α1-antitrypsin polymers
While the precise role of the RCL in polymerization is conten-
tious, its fundamental importance has been shown consistently in
many studies [2,6,8,10,22–24]. The extant models of polymeriz-
ation (Figure 1B) predict burial of at least some of the residues in
the P14 to P4 region, and it has been found that oligomerization is
blocked by peptides spanning P7-P2 [35,36] with the critical sites
of interaction found to be P6 and P4 [37]. All models anticipate
an interaction – inter- or intra-molecular – that is consistent with
the positions of the inserted RCL residues in accordance with the
canonical cleaved conformation (Figure 1A). We sought to probe
the role of different RCL residues in the formation of polymers.
Accordingly, four double mutants (P14P12, P10P8, P6P4 and P2P1′ )
and two single mutants (P6 and P4) were generated.
It is clear that the cellular machinery affects the polymeriz-
ation process in vivo, as approximately 70 % of synthesized Z
α1-antitrypsin is degraded by endoplasmic reticulum-associated
degradation [38]. In order to explore the effect of the mutants in
this context, they were investigated using a COS-7 cell model
that expresses the common severe Z mutant (E342K) of α1-
antitrypsin. Cells were transiently transfected with pcDNA-based
constructs to induce expression, and grown for 24 h before
harvest; expressed protein levels were evaluated by sandwich
ELISA.
The results revealed that while there was no significant dif-
ference in total intracellular α1-antitrypsin, the mutants exhib-
ited marked variation in the accumulation of intracellular α1-
antitrypsin polymers (Figure 1C), as detected by the 2C1 mono-
clonal antibody [21]. Substitutions at P14P12, P6P4 and P4 led
to a marked decrease in polymer levels, but the reduction seen
with the P10P8 variant did not reach statistical significance, and
for the P6 and P2P1′ loop mutants, the intracellular polymer bur-
den was equivalent to the Z α1-antitrypsin control. Notably, the
P6P4 and P4 variants showed an equivalent repression of polymer-
ization, demonstrating a lack of additive effect between the P6
and P4 positions. Overall, these data suggest that during polymer-
ization of the Z variant within the ER, the P10–P6 positions rep-
resent a partition between two functionally distinct RCL regions,
which potentially exert different effects on the polymerization
mechanism.
Mutations within the RCL exert a minimal effect on
overall stability
In order to explore in detail the effect of the mutations on the
polymerization of α1-antitrypsin, the variants were produced us-
ing an E. coli expression system. The control protein used in all
in vitro experiments was a C232S point mutant of the M allele of
antitrypsin (ATC232S) which has been found to behave identically
to wild-type protein [22]. CD in the far-UV range was used to
determine whether the mutants had an altered secondary struc-
ture. The loop mutants were all found to share a similar far UV
CD profile to ATC232S (Figure 2A), and had melting temperatures
in a SYPRO Orange stability assay that were no greater than
2.0 ◦C above that of the control protein (Table 1). In contrast,
almost no inhibitory activity against chymotrypsin was observed
for any of the mutants, with the exception of P10P8, which dis-
played approximately 20 % of wild-type activity (Table 1). This
is consistent with the mutated sites affecting the ability to insert
into β-sheet A while not affecting overall structure in the native
conformation and having a minimal effect on global native state
stability.
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Figure 2 Characteristics of the mutants and heat-induced polymerization monitored by FRET
(A) Assessment of the integrity of wild-type and reactive loop mutants by CD. CD spectra of the reactive loop mutants,
at 0.5 mg/ml in 10 mM Na2HPO4/NaH2PO4 pH7.4, recorded between 260 and 190 nm, show a similar profile to that of
the wild-type protein. The spectra are the average of at least four independent experiments. (B) Monomer and samples
containing predominantly dimer or trimer were separated by gel filtration of polymerized material using a Superdex 200
column (inset gel). Different ratios of the oligomer fractions were mixed with monomer such that the total concentration of
each sample was 0.1 mg/ml, and combined with 4 μM NTA-ATTO550 and 4 μM NTA-ATTO647N. The ratio of fluorescence
at 665 nm to that at 575 nm upon excitation at 488 nm was recorded. The measurements shown are from two separate
experiments, each using the two different oligomer preparations. The FRET signal varied inversely with the amount of
monomer on non-denaturing PAGE. A linear relationship between oligomer concentration and FRET signal is in keeping
with previous biophysical studies of α1-antitrypsin polymerization [14]. Inset fluorescence spectra, normalized for the
emission maximum of ATTO550, show a distinct FRET peak (indicated by an asterisk ‘*’) for recombinant α1-antitrypsin
heated at 60 ◦C for 10 min in the presence of 4 μM NTA-ATTO550 and 4 μM NTA-ATTO647N dyes, but not for the unheated
control or in the absence of either dye. (C) A 600 μl sample of recombinant α1-antitrypsin (thick lines) or plasma antitrypsin
(thin lines) at 0.1 mg/ml in 10 mM Na2HPO4/NaH2PO4, 100 mM NaCl in the presence (unbroken lines) or absence (broken
lines) of 4 μM NTA-ATTO550/4 μM NTA-ATTO647N was heated from 20 to 95 ◦C at a rate of 1 ◦C min−1 in a Jasco-J810
spectropolarimeter and the ellipticity at 222 nmmeasured across a 2 mm pathlength. Values were scaled to occur between
0 and 1.0; curves shown are the average of two experiments and error bars indicate the difference between the duplicate
measurements. The midpoint of denaturation of recombinant α1-antitrypsin in these buffer conditions is 59.6+−0.1 ◦C
in the absence of the reporter dyes and 58.0+−0.4 ◦C in the presence of the dyes, and the respective midpoints for
the plasma protein are 64.0+−0.1 and 63.8+−0.1 ◦C. (D) 2 μg α1-antitrypsin (lane A) was combined with different molar
ratios of bovine α-chymotrypsin (indicated by numbers at the top of the gel) in chymotrypsin assay buffer for 15 min at
room temperature. Samples were mixed with SDS loading buffer without boiling and separated on an SDS/PAGE(4–12%
gel) bis-Tris PAGE, and visualized by Coomassie Brilliant Blue. The position of the α1-antitrypsin–bovine α-chymotrypsin
complex and α1-antitrypsin in the native and cleaved forms are indicated by the E–I, IN and IC labels, respectively.
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RCL in intermediate formation
Figure 3 Characterization of the FRET assay
(A) The FRET-based polymerization assay was conducted using different concentrations of ATC232S at 55 ◦C in the presence
of 2 μM dyes, and the resulting rate constants, kapp,fr, were plotted. (B) The rate of polymerization reported by the FRET
assay varied as a function of dye concentration. Linear regression of the natural logarithm of the apparent rate constant,
kapp,fr, permitted extrapolation of the rate in a dye-free solution, shown for the control (ATC232S) protein at 50, 55 and 60 ◦C.
Each data point is the result of at least three independent experiments and error bars show the standard error of the
mean. (C) Polymerization progress curves for recombinant control α1-antitrypsin and loop variants at 55 ◦C were corrected
for the effect of the NTA-ATTO dyes on apparent rate, as described in the text, and averaged. Samples were prepared
at a concentration of 0.1 mg/ml in polymerization buffer with 2–8 μM NTA-ATTO550 and NTA-ATTO647N. Fluorescence
was monitored continuously on an ABI 7900HT instrument upon excitation with the 488 nm laser and the FRET efficiency
calculated; the normalized values are shown as the fraction of polymerized material present in the sample.
Table 1 Biophysical and biochemical characteristics of
recombinant wild-type and RCL mutants of α1-antitrypsin
Variants were assessed for their midpoint of denaturation, SI and asso-
ciation rate constant (kass) against bovine α-chymotrypsin. The results
are the mean of at least three independent experiments. n.i., non-in-
hibitory (less than 1% residual inhibitory activity).
Variant Tm (◦C)* SI† kass (M−1 s−1) kass•SI
ATC232S 55.0 1.1+−0.02 1.5+−0.2×106 1.5×106
P2P1′ 55.0 100+−9 – –
P6 54.5 n.i. – –
P4 55.0 n.i. – –
P6P4 55.0 89+−7 – –
P10P8 56.0 4.56+−0.32 1.2+−0.2×105 5.7×105
P14P12 57.0 n.i. – –
*All standard errors were less than precision of the technique on the instrument
(+−0.5 ◦C).†Standard errors were calculated by regression of a transformed linear equation with
the intercept at the abscissa as a parameter.
Development of a FRET-based assay to follow
oligomerization
Spectroscopically, serpin polymerization is typically followed
using approaches that monitor coincident changes in the intrinsic
properties of the molecule. We sought to use a technique that
directly reports increases in physical proximity during oligo-
merization. For this purpose, we developed a FRET-based assay
by exploiting the presence of a hexa-histidine affinity tag on
the recombinant proteins. Ni-NTA-conjugated ATTO-550 and
647N are commercially available dyes that are able to inter-
act non-covalently with these affinity tags. In the presence of
pre-polymerized α1-antitrypsin, NTA-ATTO-550 was found to
excite NTA-ATTO-647N via FRET (Figure 2B, inset top left),
with the magnitude of the signal proportional to the amount of
oligomer present (Figure 2B, graph). The presence of the dyes
led to a 1.6 ◦C decrease in thermal stability as determined using
a CD-based thermal shift assay (Figure 2C), but had no effect
on the ability to form SDS-stable complexes with bovine α-
chymotrypsin (Figure 2D). It has previously been noted that the
hexa-histidine tag increases stability of the recombinant protein
[14], and this probably represents a partial negation of this effect,
as the presence of the dye had no effect on the thermal stability
of non-tagged plasma α1-antitrypsin (Figure 2C).
In conjunction with a laser-excited real-time thermal cycler,
it was possible to monitor the formation of polymer of multiple
low-volume (20 μl) samples concurrently in a microplate assay
(Figure 3A). Non-linear regression analysis was performed using
differential equations describing several alternative possible re-
action schemes with COPASI [39]. The simplest kinetic reaction
scheme that minimized the RMS deviation from the data was:
M −→
k1,fr
Ipol + Ipol −→
kapp,fr
P
where k1,fr is a first-order activation rate constant, kapp,fr is the
apparent second-order association rate constant, M is a non-
activated monomer, Ipol a polymerization intermediate and P
the species reported by FRET. Exploration of alternative path-
ways with greater complexity, including reversible activation and
mixed intermediate species, failed to yield improved fits; simil-
arly, removal of the initial unimolecular step resulted in a much
poorer correspondence with the data.
It was ultimately found that a value for kapp,fr could be ob-
tained with optimal numerical stability by fitting the integrated
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Table 2 Effect of mutations on polymerization
The apparent rate of polymerization, determined using the FRET-based assay, is shown for each of the α1-antitrypsin loop mutants,
at 0.1 mg ml−1. The aggregate number of independent observations for a variant at each temperature is shown, and standard
errors are reported. The apparent energy of activation was calculated by application of Arrhenius’ law.
kapp,fr (s−1)
Variant 50 ◦C n 55 ◦C n 60 ◦C n Eact (kJ mol−1)
ATC232S 2.1+−0.30×10−4 31 1.6+−0.17×10−3 32 1.0+−0.11×10−2 41 3.6+−0.12×102
P14P12 0.58+−0.074×10−4 18 0.43+−0.18×10−3 17 2.4+−0.020×10−2 18 3.3+−0.32×102
P10P8 0.72+−0.15×10−4 20 0.66+−0.21×10−3 18 0.28+−0.026×10−2 18 3.3+−0.29×102
P6P4 0.098+−0.075×10−4 15 0.44+−0.10×10−3 29 0.55+−0.12×10−2 21 5.5+−0.53×102
P6 0.37+−0.071×10−4 16 0.70+−0.14×10−3 20 1.0+−0.37×10−2 17 5.0+−0.34×102
P4 1.1+−0.47×10−4 13 1.1+−0.28×10−3 32 7.8+−0.27×10−2 17 3.8+−0.47×102
P2P1′ 2.2+−0.79×10−4 13 1.7+−0.15×10−3 22 1.2+−0.21×10−2 18 3.6+−0.26×102
second-order rate equation (as detailed in the Materials and Meth-
ods section). However, it was not possible to derive robust values
for k1,fr using this method, in which the presence of Ipol could
only be inferred from the lack of conformity of an initial part
of the curve to the second-order rate model. As equation (2) im-
plicitly represents the concentration of polymer at a given time
point as a proportion of a final steady-state value, points could
be excluded below a nominal threshold value to ensure that kapp,fr
was determined from a region subject only to second-order time
dependence. It was found that a cutoff of 25 % of the plateau
FRET signal maximized the number of data points considered
while effectively excluding the region of the curve subject to the
first-order conversion of M to Ipol.
The resulting second-order rates were proportional to α1-
antitrypsin concentration (Figure 3A), confirming that the assay
was reporting a concentration-dependent bi-molecular step. The
slope of the regression corresponds with a rate of polymerization
of 4.3 +− 0.3 × 102 M− 1 s− 1. The linearity of this relationship, in
the context of the reaction scheme shown above, indicates that
the activation step was not rate-limiting.
When experiments were performed in the presence of dif-
ferent concentrations of ATTO-NTA, a linear relationship was
also found between the natural logarithm of kapp,fr and the dye
concentration used (Figure 3B). This enabled the derivation of
a theoretical rate in the absence of dye. The resulting corrected
rates were in excellent agreement with other measures of poly-
merization, as detailed below.
Mutations at P6P4 increase the activation energy
of polymerization
Progress curves were generated using the FRET-based assay for
each α1-antitrypsin mutant at 50, 55 and 60 ◦C at a fixed con-
centration of 0.1 mg/ml (Figure 3C), and the dye-corrected ap-
parent rate constant, kapp,fr, was determined under each condition
(Table 2). At least three independent experiments were performed
at each temperature at three concentrations of dye. The mutants
displayed a range of behaviours, demonstrating differential ef-
fects of the mutations at different sites in the RCL. Only P2P1′ be-
haved in a wild-type fashion. At 50 ◦C, the rate of polymerization
followed the order P6P4<P6<P14P12<P10P8<P4<ATC232S/P2P1,
from slowest to fastest. At 55 ◦C, P6P4 and P14P12 were found to
be the most resistant to polymer formation. At 60 ◦C, the barrier
to polymerization was sufficiently reduced such that the vari-
ants in the P6-P1′ range demonstrated similar rates to the control;
however, the P14P12 and P10P8 variants remained slower. It is
interesting to note that the behaviours of the P6 and P4 variants
deviate in this assay from that observed in cells in the presence
of the Z mutation (Figure 1). As oligomers in both contexts are
recognized by the 2C1 anti-pathogenic polymer antibody, it is
unlikely that this is the product of fundamentally different mech-
anisms of polymerization; however it does indicate there are dif-
ferences in the molecular details. This may reflect the difference
between a specific destabilization of the top of β-sheet A by the
Z point mutation [6,7,17] and a more general destabilization of
the β-sheet A under thermal stress.
In accordance with Arrhenius’ law, a linear relationship was
found between the natural logarithm of the rates and the inverse
of the experimental temperature (Figure 4A). From the slopes of
these regressions, it was possible to calculate the apparent energy
of activation (Eact) for the polymerization reaction. The ATC232S
control variant was determined to have an activation energy of
polymerization of ∼360 kJ mol− 1 (Table 2). This analysis re-
vealed a striking behaviour for the P6 and P6P4 mutants: steeper
curves with respect to the other variants were consistent with an
additional barrier to activation of 140–190 kJ mol− 1. Notably,
despite the considerable resistance of the P10P8 and P14P12 α1-
antitrypsin variants to polymerization, these mutants had com-
parable activation energies to the ATC232S control (Figure 4B
and Table 2), indicating their effects are manifested during the
unimolecular activation phase rather than the multimolecular as-
sociation phase.
Congruence between FRET and intrinsic
fluorescence-based assays of polymerization
As polymerization is the consequence of distinct activation and
self-association processes, we sought to determine whether the
effects of the mutations could be explained by differences in
intermediate formation. It has been observed previously that in-
termediate formation can be followed spectroscopically by CD,
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Figure 4 Apparent rate constants calculated for activation and polymerization of control α1-antitrypsin and reactive
loop mutants
(A) The inverse relationship between the natural logarithm of the apparent rate of polymerization, kapp,fr (calculated for
each variant as shown in Figure 2D), and temperature was used to determine the energy of activation of the reaction,
Eact. Each data point is from least ten independent experiments. (B) The calculated energy of activation, Eact, for the
heat-induced polymerization of each variant is shown. (C) The change in intrinsic tryptophan fluorescence was monitored
for the variants at 55 ◦C using an LS55B instrument with a stirred cuvette and excitation at 280 nm and emission at
340 nm (open squares). Protein concentration was 0.1 mg/ml in 800 μl polymerization buffer. Values shown (kapp,fl) are
from three to five independent experiments and are the result of fitting a single exponential equation to the data [14].
The combined results of the FRET assay at this temperature are shown for comparison (kapp,fr) interpolated from the linear
regressions in panel (A) (closed circles). (D) The change in fluorescence in the presence of 10 μM bis-ANS was followed
at 55 ◦C in a cuvette or plate reader format, and fitted to a single exponential equation (closed circles). The resulting rates
(k1,ans) were calculated from seven independent experiments. Alongside these values are the rates of change of circular
dichroic ellipticity at 222 nm (k1,cd), calculated from two to three independent experiments for each point (open squares).
An asterisk ‘*’ indicates a significant decrease (P= 0.035) with respect to the control as determined by one-way ANOVA
using the Bonferroni multiple test correction.
ANS or bis-ANS binding, and by two-phase analysis of change
in intrinsic tryptophan fluorescence [14,40].
Unimolecular activation of plasma-derived α1-antitrypsin is
associated with an increase in fluorescence which is of interme-
diate magnitude to that seen with subsequent polymerization [14].
This indicates that distinct changes in the tryptophan environment
occur during each phase. For all of the variants, at 55 ◦C trypto-
phan fluorescence was found to follow only a single exponential
function. This lack of a detectable second ‘fast’ phase for the
recombinant protein, when compared with glycosylated plasma-
derived α1-antitrypsin, has been described previously [14]. Thus,
the fluorescence signal is dominated by the spectroscopic changes
that occur during the multimolecular association phase. It is note-
worthy that the fitted rates (kapp,fl) were in close agreement with
those obtained using the FRET approach (Figure 4C), which is
a direct measure of the increase in physical proximity associated
with oligomerization. In addition to providing independent sup-
port for the utility of the FRET method, this result further affirms
that intrinsic fluorescence reports only the self-association phase
of the pathway for recombinant α1-antitrypsin.
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Figure 5 Intermediate formation monitored by CD
(A) Change in secondary structure content was monitored at 222 nm in a 2 mm pathlength cuvette containing 20 mM
Na2HPO4/NaH2PO4 pH 7.4 pre-warmed to 55 ◦C. The progress curves shown are the aggregate of three replicate experi-
ments, normalized to the starting CD signal, and fit using a two-phase exponential equation. (B) The normalized change
in ellipticity for the ATC232S control at 55 ◦C is shown. Periodically, an aliquot containing 2 μg of material was removed and
snap frozen, before separation on a 4–12% (w/v) acrylamide non-denaturing gel; positions in the figure are relative to the
time at which they were removed. (C) The rate of change of the CD signal at 55 ◦C at different concentrations of ATC232S
is shown. (D) A trend is evident between the magnitude of the CD signal change and the rate of polymerization of the
variants.
bis-ANS reports a decreased rate of activation for
P14P12 α1-antitrypsin
At 55 ◦C, the bis-ANS dye was found to report a phase with
significantly faster rates (k1,ans) for all proteins than that repor-
ted by the FRET and intrinsic fluorescence assays (Figure 4D,
circles). This is consistent with its ability to detect an activation
step that precedes polymer formation [40]. Interestingly, how-
ever, only P14P12 showed a significant decrease in the rate of
activation with respect to the ATC232S control (one-way ANOVA,
P < 0.05). These residues are known in other serpins to partially
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Table 3 Rate and magnitude of the structural change reported
by CD at 55 ◦C
The plateau value reflects the magnitude of the change from the start-
ing CD ellipticity measurement. Parameters were calculated from fit-
ting a two-phase exponential equation to the combined data from at
least three independent experiments. Standard errors from the fit are
reported.
Variant k1,cd (s−1) k2,cd (s−1) Plateau
ATC232S 2.7+−0.07×10−3 – 0.85+−0.0011
P14P12 2.8+−0.31×10−3 2.4+−0.26×10−4 0.89+−0.0031
P10P8 2.0+−0.94×10−3 2.8+−0.34×10−4 0.87+−0.00029
P6P4 4.9+−0.56×10−3 2.1+−0.30×10−4 0.89+−0.0025
P6 3.9+−0.37×10−3 1.8+−0.36×10−4 0.91+−0.0017
P4 4.4+−0.25×10−3 14+−1.7×10−4 0.89+−0.0017
P2P1′ 2.9+−0.14×10−3 2.6+−0.32×10−4 0.83+−0.0017
insert into the top of β-sheet A, and are the first to insert during
an inhibitory interaction. Combined with the observation that at
non-polymerizing temperatures, bis-ANS is able to interact with
the Z variant of α1-antitrypsin but not wild-type [17], it is prob-
ably that this difference in rate reflects an early activation step
involving the opening of β-sheet A and initial insertion of these
residues of the RCL.
Differential effects on the rate of circular dichroic
change during polymerization
The unimolecular phase of polymerization can be followed using
CD spectroscopy at 222 nm, which reports changes in secondary
structure content [14]. As the bis-ANS data did not account for
differences in the rate of polymerization, and since the use of an
ANS-based dye may perturb structural equilibria [19], we used
this technique to explore other potential effects on the activation
to Ipol.
A pronounced initial decrease in ellipticity for all proteins
was observed within approximately 1200 s (Figure 5A), dur-
ing which time non-denaturing gel analysis revealed minimal
polymer formation (Figure 5B). Varying serpin concentration
failed to have a significant effect on the shape of the curve (Fig-
ure 5C) over this time frame, suggesting CD indeed reports a
pre-oligomerization activation step. The CD data were expressed
as a function of starting ellipticity, and fit to a two-phase exponen-
tial decay equation. Surprisingly, the P10P8 and P14P12 mutants
were not significantly different in the early ‘fast’ phase from the
ATC232S control, and the P6, P4 and P6P4 variants exhibited an
increased rate despite their repression of polymerization (k1,cd in
Table 3). This conflicting behaviour indicates that the underly-
ing structural change represented by the increase in CD is not a
rate-limiting step in the polymerization of these variants.
It has been noted previously that CD of plasma α1-antitrypsin
reports a single transition consistent with activation and not poly-
merization [14]. The behaviour of the control variant is consistent
with this. While the CD progress curves of the mutants demon-
strated a measurable second phase, the significance of this was
not clear, as the rate (k2,cd) did not appear to correlate with other
measures of polymerization or activation (Table 3). This trans-
ition may therefore represent a secondary structural change not
directly associated with the polymerization mechanism.
The amplitudes of the curves themselves reflect differing over-
all degrees of secondary structural change over the course of
the experiment. It was found that the magnitude of this change
showed a strong linear trend against the rate of polymerization
of the variants (Table 3 and Figure 5D). At a molecular level,
this could be the result of α1-antitrypsin molecules adopting two
distinct structural states that contribute differentially to the CD of
the sample. It is unlikely that these two states represent sequential
intermediates on a single reaction path, as the progress curves do
not converge to a common CD value; this lack of convergence
also indicates that the different contributions to the CD signal
persist during polymer formation. When expressed as the frac-
tional deviation from the starting CD value, extrapolation of the
linear regression to k1,cd = 0 s− 1 yielded an intercept of 0.0807,
indicating that one of the components had lost about 8 % of the
measured secondary structure signal at 222 nm with respect to
the monomer.
Although this analysis was not possible for the second com-
ponent, it could be inferred from the linear relationship that the
second component is required for polymerization to occur, that
is, the first component is unable to self-associate. Polymerization
by association between ‘donor’ and ‘acceptor’ molecules could
be one explanation for these observations. Differences in popula-
tion of these two states would accordingly influence the apparent
rate of inter-molecular association, and explain why, in the ab-
sence of the increased energy of activation observed with the
P6P4 and P6 variants, the P14P12, P10P8 and P4 variants result in a
reduced rate of polymerization.
Conclusions: the dichotomous behaviour of the RCL
mutants
Mutations in distinct regions of the RCL of the Z variant of α1-
antitrypsin – at P14P12 and P4 – are able to significantly affect
accumulation of polymers in cells. In vitro, the P14P12 mutant
decreases the rate of polymerization, in part by interfering with
an initial insertion of the RCL at an early stage in the pathway.
This effect is consistent with the three extant models of polymer-
ization (Figure 1B). In the context of the RCL-exchange models,
pre-insertion of the P12 and P14 residues coincides with opening
of β-sheet A, which in the case of the loop-sheet polymer, would
ultimately accommodate the loop of a second molecule. In the
β-hairpin model, this step foreshadows the destabilization and
loss of strand 5A. When considered, on the other hand, through
the prism of the C-terminal polymer, this insertion step precedes
a cascading RCL as the molecule transitions to a latent-like con-
formation.
The effectiveness of this mutant as a polymerization blocker
in cells has an important consequence for the polymerization
pathway in vivo. The P14 and P12 positions, in the partially inserted
form, are situated in close proximity to the strands 4B and 5B
that are displaced in the C-terminal model, and their mainchain
atoms form hydrogen bonds with adjacent β-strands 3A and
5A. This strongly suggests that, regardless of the polymer model
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considered, the polymerizing species is in a near-native state with
respect to the ‘breach’ region at the top of β-sheet A.
In contrast, P6P4 does not decrease the rate of early changes
reported by bis-ANS or CD, but increases the activation energy
required to transit between the intermediate ensemble these meth-
ods report, and the terminal self-associated form. As this increase
is reflected in the intermolecular rate constant, this is most likely
the consequence of interference with an intermolecular interac-
tion. It is nevertheless possible that the mutant interferes with the
progression to a late-stage intermediate form; however it is note-
worthy that the P14P12 variant shows no effects on the activation
energy despite directly affecting the bis-ANS-binding interme-
diate state, arguing against significant influence of the first-order
step on the calculation of the second-order rate constant.
In the case of the C-terminal polymer, self-insertion of P6P4
would represent a kinetic barrier in the transition to the latent-
like activated species. At this stage, strand 1C and possibly the
C-terminus will need be disengaged, and the situation of the in-
coming P6P4 residues in the bottom half of the A-sheet beneath
the F-helix and hF-s3A loop may amplify the energetic cost of
the mutations (Figure 1A, right panel). Loop-exchange models
suggest that the requirement to partly displace this helix would
enhance the ability of the mutations to interfere with the inter-
molecular association. A common underlying interpretation is
that the structural character of this region, which includes the
F-helix and hF-s3A loop, provides an energetic barrier at the late
stage of polymer formation. The efficacy of this mutant in cells
therefore supports a polymerogenic species with an intact F-helix
and underlying β-sheet A.
It is noteworthy that the P10P8 mutant has only an intermediate
effect on polymerization. These residues are expected to be posi-
tioned near the ‘shutter’ region that regulates opening of β-sheet
A during insertion, and are situated in close proximity to the C-
terminal portion of the F-helix that has been found to undergo
remodelling during polymerization [41]. In light of the observa-
tion that this mutant retains some inhibitory activity, it may be
that once sheet opening has been initiated, these positions have a
limited ability to prevent self-insertion (C-terminal model) or that
they play a minor role in any possible inter-molecular interactions
(loop-exchange models). Indeed, when the latter models are con-
sidered, it appears that in the presence of the Z mutation that the
bridging ‘linker’ region is more extensive than in heat-generated
polymers and includes P6 as well as the P10P8 residues.
In conclusion, these data support a polymerization reaction
scheme in which a structural transition precedes the opening of
β-sheet A, followed by an obligate partial insertion of the P14P12
residues, and ultimately a kinetic barrier involving the insertion
of residues P6P4 into β-sheet A. CD provides evidence for a
direct link between intermediate structure and polymerization
rate. Finally, in cells, polymerization most likely proceeds from
a near-native state.
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